{"webUser":null,"request_id":"4235bf54b8a1d7a72c42c2307dcf9331"}
{"flashNotices":[],"request_id":"4235bf54b8a1d7a72c42c2307dcf9331"}

OncLive® On Air / FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.